ARQT logo

Arcutis Biotherapeutics, Inc. (ARQT) Total Debt

Annual Total Debt:

$110.58M-$95.33M(-46.30%)
December 31, 2024

Summary

  • As of today, ARQT annual total debt is $110.58 million, with the most recent change of -$95.33 million (-46.30%) on December 31, 2024.
  • During the last 3 years, ARQT annual total debt has risen by +$33.03 million (+42.59%).
  • ARQT annual total debt is now -46.30% below its all-time high of $205.92 million, reached on December 31, 2023.

Performance

ARQT Total Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherARQTbalance sheet metrics

Quarterly Total Debt:

$110.16M-$637.00K(-0.57%)
June 30, 2025

Summary

  • As of today, ARQT quarterly total debt is $110.16 million, with the most recent change of -$637.00 thousand (-0.57%) on June 30, 2025.
  • Over the past year, ARQT quarterly total debt has dropped by -$97.40 million (-46.93%).
  • ARQT quarterly total debt is now -47.08% below its all-time high of $208.18 million, reached on September 30, 2024.

Performance

ARQT Quarterly Total Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherARQTbalance sheet metrics

Total Debt Formula

Total Debt = Short Term Debt + Long Term Debt

ARQT Total Debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year-46.3%-46.9%
3Y3 Years+42.6%+40.9%
5Y5 Years+10000.0%+2885.4%

ARQT Total Debt Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Year-46.3%+42.6%-47.1%at low
5Y5-Year-46.3%>+9999.0%-47.1%+2871.8%
All-TimeAll-Time-46.3%>+9999.0%-47.1%>+9999.0%

ARQT Total Debt History

DateAnnualQuarterly
Jun 2025
-
$110.16M(-0.6%)
Mar 2025
-
$110.80M(+0.2%)
Dec 2024
$110.58M(-46.3%)
$110.58M(-46.9%)
Sep 2024
-
$208.18M(+0.3%)
Jun 2024
-
$207.56M(+0.4%)
Mar 2024
-
$206.74M(+0.4%)
Dec 2023
$205.92M(+1.7%)
$205.92M(+0.4%)
Sep 2023
-
$205.07M(+0.4%)
Jun 2023
-
$204.22M(+0.4%)
Mar 2023
-
$203.38M(+0.4%)
Dec 2022
$202.54M(+161.2%)
$202.54M(+0.4%)
Sep 2022
-
$201.68M(+158.0%)
Jun 2022
-
$78.17M(+0.4%)
Mar 2022
-
$77.86M(+0.4%)
DateAnnualQuarterly
Dec 2021
$77.56M(+1462.4%)
$77.56M(+1382.9%)
Sep 2021
-
$5.23M(+1.8%)
Jun 2021
-
$5.14M(+1.7%)
Mar 2021
-
$5.05M(+1.7%)
Dec 2020
$4.96M(+1516.9%)
$4.96M(+33.9%)
Sep 2020
-
$3.71M(+0.5%)
Jun 2020
-
$3.69M(+1297.7%)
Mar 2020
-
$264.00K(-14.0%)
Dec 2019
$307.00K(>+9900.0%)
$307.00K(-11.8%)
Sep 2019
-
$348.00K(-10.5%)
Jun 2019
-
$389.00K(>+9900.0%)
Mar 2019
-
$0.00(0.0%)
Dec 2018
$0.00(0.0%)
$0.00(0.0%)
Sep 2018
-
$0.00
Dec 2017
$0.00
-

FAQ

  • What is Arcutis Biotherapeutics, Inc. annual total debt?
  • What is the all-time high annual total debt for Arcutis Biotherapeutics, Inc.?
  • What is Arcutis Biotherapeutics, Inc. annual total debt year-on-year change?
  • What is Arcutis Biotherapeutics, Inc. quarterly total debt?
  • What is the all-time high quarterly total debt for Arcutis Biotherapeutics, Inc.?
  • What is Arcutis Biotherapeutics, Inc. quarterly total debt year-on-year change?

What is Arcutis Biotherapeutics, Inc. annual total debt?

The current annual total debt of ARQT is $110.58M

What is the all-time high annual total debt for Arcutis Biotherapeutics, Inc.?

Arcutis Biotherapeutics, Inc. all-time high annual total debt is $205.92M

What is Arcutis Biotherapeutics, Inc. annual total debt year-on-year change?

Over the past year, ARQT annual total debt has changed by -$95.33M (-46.30%)

What is Arcutis Biotherapeutics, Inc. quarterly total debt?

The current quarterly total debt of ARQT is $110.16M

What is the all-time high quarterly total debt for Arcutis Biotherapeutics, Inc.?

Arcutis Biotherapeutics, Inc. all-time high quarterly total debt is $208.18M

What is Arcutis Biotherapeutics, Inc. quarterly total debt year-on-year change?

Over the past year, ARQT quarterly total debt has changed by -$97.40M (-46.93%)
On this page